Moderna’s Next-Gen Shot Approved

HEAVILY 30% 70% Saturday, May 31, 2025, 11:22 am

The FDA has given the green light to Moderna’s new COVID-19 vaccine, designed differently from its Spikevax predecessor. The approval comes as the science community and public alike hope that this next-generation vaccine will offer improved protection for vulnerable segments of the population, marking yet another twist in the long saga of COVID countermeasures.

Bluesky: @us-political-news.bsky.social, @newnarrative.bsky.social, @cbsnews.com.web.brid.gy

theepochtimes.com / FDA Approves Moderna’s New COVID-19 Vaccine

The vaccine's design differs from Spikevax, Moderna's shot that has been available.

axios.com / FDA approves new Moderna COVID-19 vaccine

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to 64 years old with at least one underlying condition that could put them at risk of severe infection, the company said Saturday.The big picture: It was the first such approval…

cbsnews.com / Moderna's new COVID-19 vaccine mNexspike approved by FDA

The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.

permalink / 3 stories from sources in 45 hours ago #healthcare #cdc #covid #moderna

More Top Stories...

Senate split deepens over contentious healthcare megabill debate

Lawmakers are locked in a high-stakes standoff over the new healthcare megabill. As Medicaid moderates hold crucial sway and Republican senators cast doubts, partisan divisions intensify. This legislative tug-of-war could reshape national healthcare policies, leaving critics shaking their heads at the chaos. More...

Controversial One Big Beautiful Bill Ignites Fiscal Outrage and Debate

The flagship tax-and-spending proposal backed by President Trump has come under fire after revelations of a contentious paragraph that could hike deficits by $2.3 trillion over a decade. Critics and fiscal watchdogs are questioning the bill’s hidden costs as GOP allies launch a high-stakes lobbying effort to shore up support. More...

Trump’s Tariff Strategy Faces Unprecedented Legal Scrutiny

President Trump’s aggressive tariff policy is now under judicial fire as conservative legal scholars and critics from across the aisle decry the president’s unilateral moves. Courts have begun challenging the statutory basis for these steep import duties, forcing a constitutional debate that underscores the limits of executive power. More...

Trump-Backed Polish Presidential Victory Seals a New Chapter

In Poland’s heated election runoff, conservative candidate Karol Nawrocki—backed by Trump—narrowly clinched the presidency, marking a pivotal political shift. Observers note the unexpected yet definitive win that reshapes the nation’s political landscape, proving electoral surprises are never dull. More...

US Visa Revocation Plan Sparks Political Backlash

The administration’s move to revoke visas for Chinese students has ignited intense political criticism. Analysis of the policy’s potential fallout was matched by a sharp rebuke from a prominent lawmaker, who deemed the plan “terribly misguided.” The controversy underscores rising tensions over academic freedom and international relations. More...

Related Tags